Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2019 08:40 ET | Source: Schall Law

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
January 01, 2019 13:01 ET | Source: Schall Law

DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Jan. 01, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
December 26, 2018 08:30 ET | Source: Schall Law

EARLY JANUARY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Dec. 26, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
December 18, 2018 12:20 ET | Source: Schall Law

UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Dec. 18, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
December 11, 2018 16:21 ET | Source: Schall Law

INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
December 06, 2018 11:48 ET | Source: Schall Law

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
November 27, 2018 11:11 ET | Source: Schall Law

INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Nov. 27, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
November 21, 2018 12:47 ET | Source: Schall Law

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
August 02, 2018 16:05 ET | Source: TESARO, Inc.

TESARO Announces Second-Quarter 2018 Operating Results

ZEJULA® Q2 net sales totaled $54 million compared to $26 million for Q2 2017QUADRA sNDA submission planned for Q4 2018PRIMA Phase 3 ZEJULA monotherapy trial in first-line ovarian cancer regardless of...
May 03, 2018 16:05 ET | Source: TESARO, Inc.

TESARO Announces First-Quarter 2018 Operating Results

ZEJULA Q1 net sales totaled $49 millionEnrollment completed in Phase 3 PRIMA first-line ovarian cancer monotherapy trial TOPACIO platinum-resistant ovarian cancer and triple-negative breast cancer...

Next Page keyboard_arrow_right